Truist Financial Corp Zai Lab LTD Transaction History
Truist Financial Corp
- $71.8 Billion
- Q3 2025
A detailed history of Truist Financial Corp transactions in Zai Lab LTD stock. As of the latest transaction made, Truist Financial Corp holds 11,132 shares of ZLAB stock, worth $243,790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,132
Previous 10,389
7.15%
Holding current value
$243,790
Previous $363,000
3.86%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ZLAB
# of Institutions
167Shares Held
37.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$132 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$121 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$87.9 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$48.1 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$34.8 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.14B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...